ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$21.83
-0.46 (-2.06%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+292.9% upside
Low Target
$74.20
Average Target
$85.78
High Target
$112.10
Current Price
$21.83
Current
$21.83
$21.83
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Scenario Analysis
Bear Case
$74.20
239.9%
Low target
Base Case
$85.78
+292.9%
Avg target
Bull Case
$112.10
+413.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$31.77
-31.3% from high
52-Week Low
$11.86
+84.1% from low
50-Day SMA
$27.64
-21.0% vs SMA
200-Day SMA
$20.38
+7.1% vs SMA
RSI (14)
67.5
Neutral
Target vs 52W High
$85.78
+170.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +25.5% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.2% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.6% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.6% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -66.8% |
| INSM | Strong Buy | 26 | 92% | $143.40 | +3.1% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -26.5% |